Standout Papers

<i>IDH1</i>and<i>IDH2</i>Mutations in Glio... 1989 2026 2001 2013 4.2k
  1. IDH1andIDH2Mutations in Gliomas (2009)
    Hai Yan, D. Williams Parsons et al. New England Journal of Medicine
  2. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma (2009)
    Henry S. Friedman, Michael D. Prados et al. Journal of Clinical Oncology
  3. Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling (1989)
    E Gluckman, HE Broxmeyer et al. New England Journal of Medicine
  4. Management of glioblastoma: State of the art and future directions (2020)
    Aaron C. Tan, David M. Ashley et al. CA A Cancer Journal for Clinicians
  5. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (2007)
    James J. Vredenburgh, Annick Desjardins et al. Journal of Clinical Oncology
  6. Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma (2007)
    James J. Vredenburgh, Annick Desjardins et al. Clinical Cancer Research
  7. Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse (1999)
    W.K. Alfred Yung, Michael D. Prados et al. Journal of Clinical Oncology
  8. Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma (2010)
    John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology
  9. Temozolomide and treatment of malignant glioma. (2000)
    Henry S. Friedman, Tracy Kerby et al. PubMed
  10. Postoperative Chemotherapy and Delayed Radiation in Children Less Than Three Years of Age with Malignant Brain Tumors (1993)
    Patricia K. Duffner, Marc E. Horowitz et al. New England Journal of Medicine
  11. Recurrent Glioblastoma Treated with Recombinant Poliovirus (2018)
    Annick Desjardins, Matthias Gromeier et al. New England Journal of Medicine
  12. Phase II Trial of Gefitinib in Recurrent Glioblastoma (2003)
    Jeremy N. Rich, David A. Reardon et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 40 from Science/Nature 140 standout
Sub-graph 1 of 17

Citing Papers

Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Chemically defined cytokine-free expansion of human haematopoietic stem cells
2023 StandoutNature
27 intermediate papers

Works of Henry S. Friedman being referenced

Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells
1990
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling
1989 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Henry S. Friedman 21140 14778 8859 564 37.6k
David A. Reardon 20314 10207 8565 552 33.1k
Patrick Y. Wen 23253 12006 9683 775 41.8k
Jill S. Barnholtz‐Sloan 18897 11383 6891 433 39.7k
Alba A. Brandes 23019 9884 6491 356 33.2k
Paul Kleihues 19488 15209 6249 290 39.5k
Roger E. McLendon 18272 19151 12748 325 41.0k
Timothy F. Cloughesy 19925 10680 6199 553 32.8k
Darell D. Bigner 18253 21817 15412 619 47.4k
Warren Mason 20059 10386 5614 213 32.4k
Webster K. Cavenee 15661 27510 11287 310 49.9k

All Works

Loading papers...

Rankless by CCL
2026